Spire Health Announces Data on Use of Health Tags for Respiratory Monitoring and Chronic Pain Feedback in Adult Survivors of Childhood Cancer
San Francisco, CA, USA – WEBWIRE – Wednesday, October 14, 2020 - Spire Health, the leading digital healthcare company for continuous respiratory remote patient monitoring, announced today new data on the use of Spire Health Tags for childhood cancer survivors living with chronic pain. The study titled, RESPIRATORY MONITORING AND FEEDBACK FOR CHRONIC PAIN IN ADULT SURVIVORS OF CHILDHOOD CANCER: A MOBILE HEALTH PILOT STUDY FROM THE CHILDHOOD CANCER SURVIVOR STUDY, will be presented as an e-poster during the 52nd Annual International Society of Paedriatric Oncology Virtual Congress, October 14 - 17, 2020.
The study examined the feasibility, acceptability, and preliminary efficacy of wearable respiratory monitoring and feedback among 65 survivors of childhood cancer with chronic pain. Patients were randomized into control and intervention groups- the intervention group wore the Spire device for 30 days and completed daily breathing exercises. Both the intervention and control groups completed a set of valid and reliable self-reporting measures of pain-related disability, average pain, anxiety, sleep, depression, and negative affect at pre- and post-treatment. Post-treatment improvement was significantly greater in the intervention group wearing the Spire Health Tags compared to the control group for negative affect (Cohen’s d=0.59, p=0.02). The study findings support feasibility, acceptability, and potential efficacy of wearable respiratory monitoring/feedback.
“Approximately 40% of adult survivors of childhood cancer experience chronic pain, with 33% of these survivors also experiencing clinically significant anxiety,” said Nicole M. Alberts, Ph.D., Associate Professor, Department of Psychology, Centre for Clinical Research in Health, Concordia University and Principal Investigator. “As respiration, anxiety, and pain are interrelated, we believe continuously tracking respiration may help survivors manage physiological responses to pain. We chose to use Spire Health for this pilot study due to the extensive breadth of respiratory data and ease of use for patients. We look forward to exploring a larger scale study to assess efficacy and maintenance of this intervention.”
“This study adds to the mounting clinical evidence on the value of continuous respiratory data for patients living with chronic conditions,” said Neema Moraveji, Ph.D., Chief Science Officer at Spire Health. “Our mission remains to improve the lives of patients with chronic respiratory diseases, many of whom live with and manage chronic anxiety. We look forward to continuing to explore how Health Tags can help those living with chronic pain and anxiety manage these conditions.”
About Spire Health
Spire Health is the leading digital healthcare company for continuous respiratory monitoring and actionable feedback. The Spire Health Tag enables remote patient monitoring with unparalleled adherence and clinical-grade accuracy. Spire Health’s remote patient monitoring approach has the potential to identify and predict health events, enable early interventions, and prevent hospital admissions. Spire is backed by leading medical health investors and has received a grant from the US Department of Health and Human Services. For more information visit: www.spirehealth.com
Note: Spire Health Tags are general wellness devices that are intended to promote a healthy lifestyle and reduce the impact of chronic diseases such as COPD. Spire Health is currently pursuing FDA clearance for a future version of Health Tags for expanded remote patient monitoring applications.